PortfoliosLab logoPortfoliosLab logo
TEVA vs. KB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TEVA vs. KB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Teva Pharmaceutical Industries Limited (TEVA) and KB Financial Group Inc. (KB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TEVA achieves a 10.96% return, which is significantly lower than KB's 26.45% return. Over the past 10 years, TEVA has underperformed KB with an annualized return of -3.83%, while KB has yielded a comparatively higher 17.76% annualized return.


TEVA

1D
0.20%
1M
-4.47%
YTD
10.96%
6M
16.25%
1Y
95.54%
3Y*
66.30%
5Y*
25.53%
10Y*
-3.83%

KB

1D
4.33%
1M
3.97%
YTD
26.45%
6M
27.85%
1Y
38.73%
3Y*
46.81%
5Y*
21.60%
10Y*
17.76%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TEVA vs. KB - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TEVA
Teva Pharmaceutical Industries Limited
10.96%41.61%111.11%14.47%13.86%-16.99%-1.53%-36.45%-18.63%-46.18%
KB
KB Financial Group Inc.
26.45%56.57%45.22%10.35%-11.26%22.62%-0.46%-1.45%-28.25%65.80%

Correlation

The correlation between TEVA and KB is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (5Y)
Calculated over the trailing 5-year period

0.26

Correlation (10Y)
Calculated over the trailing 10-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Nov 12, 2001

0.24

Fundamentals

Market Cap

TEVA:

$40.83B

KB:

$40.70B

EPS

TEVA:

$1.34

KB:

₩16.37K

PE Ratio

TEVA:

25.89

KB:

10.01

PEG Ratio

TEVA:

0.20

KB:

1.11

PS Ratio

TEVA:

2.33

KB:

1.40

PB Ratio

TEVA:

4.96

KB:

1.13

Total Revenue (TTM)

TEVA:

$17.35B

KB:

₩43.88T

Gross Profit (TTM)

TEVA:

$9.03B

KB:

₩22.91T

EBITDA (TTM)

TEVA:

$3.05B

KB:

₩9.39T

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TEVA vs. KB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TEVA
TEVA Risk / Return Rank: 9393
Overall Rank
TEVA Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
TEVA Sortino Ratio Rank: 9494
Sortino Ratio Rank
TEVA Omega Ratio Rank: 9393
Omega Ratio Rank
TEVA Calmar Ratio Rank: 9191
Calmar Ratio Rank
TEVA Martin Ratio Rank: 9292
Martin Ratio Rank

KB
KB Risk / Return Rank: 7474
Overall Rank
KB Sharpe Ratio Rank: 7676
Sharpe Ratio Rank
KB Sortino Ratio Rank: 7171
Sortino Ratio Rank
KB Omega Ratio Rank: 7070
Omega Ratio Rank
KB Calmar Ratio Rank: 7979
Calmar Ratio Rank
KB Martin Ratio Rank: 7676
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TEVA vs. KB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Teva Pharmaceutical Industries Limited (TEVA) and KB Financial Group Inc. (KB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TEVAKBDifference
Sharpe ratioReturn per unit of total volatility

+1.37

Sortino ratioReturn per unit of downside risk

+1.98

Omega ratioGain probability vs. loss probability

1.47

1.21

+0.25

Calmar ratioReturn relative to maximum drawdown

4.41

2.32

+2.08

Martin ratioReturn relative to average drawdown

12.66

4.63

+8.03

TEVA vs. KB - Sharpe Ratio Comparison

The current TEVA Sharpe Ratio is 2.46, which is higher than the KB Sharpe Ratio of 1.09. The chart below compares the historical Sharpe Ratios of TEVA and KB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TEVA vs. KB - Drawdown Comparison

The maximum TEVA drawdown since its inception was -90.89%, which is greater than KB's maximum drawdown of -84.27%. Use the drawdown chart below to compare losses from any high point for TEVA and KB.


Loading charts...

Drawdown Indicators


TEVAKBDifference

Max Drawdown

Largest peak-to-trough decline

-90.89%

-84.27%

-6.62%

Max Drawdown (1Y)

Largest decline over 1 year

-21.79%

-16.74%

-5.05%

Max Drawdown (3Y)

Largest decline over 3 years

-43.70%

-34.41%

-9.29%

Max Drawdown (5Y)

Largest decline over 5 years

-43.70%

-42.89%

-0.81%

Max Drawdown (10Y)

Largest decline over 10 years

-88.41%

-66.92%

-21.49%

Current Drawdown

Current decline from peak

-48.81%

-7.96%

-40.85%

Average Drawdown

Average peak-to-trough decline

-32.00%

-40.13%

+8.13%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.72%

8.38%

-0.66%

Volatility

TEVA vs. KB - Volatility Comparison

Teva Pharmaceutical Industries Limited (TEVA) and KB Financial Group Inc. (KB) have volatilities of 10.61% and 11.13%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TEVAKBDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.61%

11.13%

-0.52%

Volatility (6M)

Calculated over the trailing 6-month period

23.72%

25.60%

-1.88%

Volatility (1Y)

Calculated over the trailing 1-year period

39.04%

35.70%

+3.34%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

42.82%

33.46%

+9.36%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

47.35%

32.79%

+14.56%

Dividends

TEVA vs. KB - Dividend Comparison

TEVA has not paid dividends to shareholders, while KB's dividend yield for the trailing twelve months is around 2.21%.


PositionTTM20252024202320222021202020192018201720162015
KB
KB Financial Group Inc.
2.21%2.92%4.98%2.81%5.78%5.27%3.97%0.00%0.00%0.00%3.10%3.05%
TEVA
Teva Pharmaceutical Industries Limited
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%3.88%3.19%1.77%

Financials

TEVA vs. KB - Financials Comparison

This section allows you to compare key financial metrics between Teva Pharmaceutical Industries Limited and KB Financial Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00T10.00T15.00T20.00T20222023202420252026
3.98B
2.71T
(TEVA) Total Revenue
(KB) Total Revenue
Please note, different currencies. TEVA values in USD, KB values in KRW

TEVA vs. KB - Profitability Comparison

The chart below illustrates the profitability comparison between Teva Pharmaceutical Industries Limited and KB Financial Group Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%90.0%100.0%20222023202420252026
49.5%
100.0%
Portfolio components
TEVA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a gross profit of 1.97B and revenue of 3.98B. Therefore, the gross margin over that period was 49.5%.

KB - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, KB Financial Group Inc. reported a gross profit of 2.71T and revenue of 2.71T. Therefore, the gross margin over that period was 100.0%.

TEVA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported an operating income of 652.00M and revenue of 3.98B, resulting in an operating margin of 16.4%.

KB - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, KB Financial Group Inc. reported an operating income of 2.71T and revenue of 2.71T, resulting in an operating margin of 100.0%.

TEVA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a net income of 369.00M and revenue of 3.98B, resulting in a net margin of 9.3%.

KB - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, KB Financial Group Inc. reported a net income of 1.97T and revenue of 2.71T, resulting in a net margin of 72.8%.


Frequently Asked Questions


TEVA and KB have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

KB has higher volatility (11.13%) compared to TEVA (10.61%). In terms of maximum drawdown, TEVA dropped -90.89% vs KB's -84.27%.

TEVA currently has the higher Sharpe Ratio (2.46 vs 1.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TEVA and KB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer